| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Franchises For Sale; Never Sell A Franchise Without A One-On-One |
|
Just Other Articles - Franchises For Sale; Never Sell A Franchise Without A One-On-One
It is so important for franchisors to pick the very best franchisees to run with in the marketplace. Without the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product best possible team it is hard to win in a highly competitive industry and that is why the interview is so importan ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in t. Many franchise buyers believe that the interview or the one-on-one with the franchisor is simply a sales tactic lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. to sell them something. This is totally wrong. The franchisor should never sell a franchise without meeting the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe franchise buyer or potential team member candidate in a one-on-one interview. If they are not exactly what the fr d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro anchisor is looking for he should not move ahead with the sale. A franchise buyer who is combative or problematic ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc in an interview is merely a foreshadowing of things to come and the franchisor is much better to walk away and ne easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ver sell the franchise. Additionally, often we find in franchising that the competition is trying to scam us into nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically giving away proprietary information by pretending to be franchise buyers. This corporate espionage is a lot like and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ a spy game. But they are much easier to catch when they are in a one-on-one interview by the questions they ask a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nd their body language, they give themselves away and you can tell that they are lying. You will get a lot of that ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a , be forewarned. Further, some government regulatory agencies acting on complaints that have come from competitor dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod will pretend to be franchise buyers and they will start asking all sorts of questions and wasting franchisor's va cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin luable time. Of course they will never show up to a one-on-one interview and lie straight to your face because in tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen my opinion they are dogs, which is another good reason to call for a one-on-one interview. This is unfortunate in t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel deed, our own government, but it is true. All these are important factors that every franchisor should know when ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust etermining if a franchise candidate is good enough for your franchising company. If they are not they need to tak y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e a walk. As a franchisor founder that built my business up from scratch over a 20 year period prior to franchisi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ng I know that a franchising company has too much at stake to risk it with unqualified or future non performing fr elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip anchisees. Don't go there and don't give away unnecessary information to spies. Please consider all this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Know It Before You Are Handed The Pink Slip Does It Really Take Money To Make Money? What It Takes To be An Entrepreneur Series: Action
|